Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2012, Article ID 263836, 10 pages
http://dx.doi.org/10.1155/2012/263836
Research Article

Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection

1Department of Infectious Diseases, Institution of Medicine, Karolinska University Hospital and Karolinska Institutet, 14186 Stockholm, Sweden
2Department of Clinical Microbiology, Institution of Laboratory Medicine, Karolinska University Hospital and Karolinska Institutet, 14186 Stockholm, Sweden
3Department of Infectious Diseases, Oslo University Hospital, Ullevål, 0424 Oslo, Norway

Received 28 February 2012; Accepted 16 April 2012

Academic Editor: Giancarlo Ceccarelli

Copyright © 2012 Piotr Nowak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Dinoso, S. Y. Kim, A. M. Wiegand et al., “Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 23, pp. 9403–9408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. D. Hazenberg, S. A. Otto, B. H. B. Van Benthem et al., “Persistent immune activation in HIV-1 infection is associated with progression to AIDS,” AIDS, vol. 17, no. 13, pp. 1881–1888, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Hellerstein, M. B. Hanley, D. Cesar et al., “Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans,” Nature Medicine, vol. 5, no. 1, pp. 83–89, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. J. V. Giorgi, L. E. Hultin, J. A. McKeating et al., “Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage,” Journal of Infectious Diseases, vol. 179, no. 4, pp. 859–870, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. S. G. Deeks and A. N. Phillips, “HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity,” Bratislava Medical Journal, vol. 338, article a3172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Brenchley, D. A. Price, and D. C. Douek, “HIV disease: fallout from a mucosal catastrophe?” Nature Immunology, vol. 7, no. 3, pp. 235–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Brenchley and D. C. Douek, “The mucosal barrier and immune activation in HIV pathogenesis,” Current Opinion in HIV and AIDS, vol. 3, no. 3, pp. 356–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Brenchley and D. C. Douek, “HIV infection and the gastrointestinal immune system,” Mucosal Immunology, vol. 1, no. 1, pp. 23–30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Brenchley, D. A. Price, T. W. Schacker et al., “Microbial translocation is a cause of systemic immune activation in chronic HIV infection,” Nature Medicine, vol. 12, no. 12, pp. 1365–1371, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Baroncelli, C. M. Galluzzo, M. F. Pirillo et al., “Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50 copies/ml HIV-1 RNA,” Journal of Clinical Virology, vol. 46, no. 4, pp. 367–370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Trøseid, P. Nowak, J. Nyström, A. Lindkvist, S. Abdurahman, and A. Sönnerborg, “Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy,” AIDS, vol. 24, no. 11, pp. 1733–1737, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Nowak, B. Barqasho, C. J. Treutiger et al., “HMGB1 activates replication of latent HIV-1 in a monocytic cell-line, but inhibits HIV-1 replication in primary macrophages,” Cytokine, vol. 34, no. 1-2, pp. 17–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Thierry, J. Gozlan, A. Jaulmes et al., “High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells,” AIDS, vol. 21, no. 3, pp. 283–292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Cassetta, O. Fortunato, L. Adduce et al., “Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines,” AIDS, vol. 23, no. 5, pp. 567–577, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Nowak, B. Barqasho, and A. Sönnerborg, “Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection,” AIDS, vol. 21, no. 7, pp. 869–871, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. U. Andersson, H. Wang, K. Palmblad et al., “High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes,” Journal of Experimental Medicine, vol. 192, no. 4, pp. 565–570, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Fiuza, M. Bustin, S. Talwar et al., “Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells,” Blood, vol. 101, no. 7, pp. 2652–2660, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Rouhiainen, S. Tumova, L. Valmu, N. Kalkkinen, and H. Rauvala, “Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin),” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 49–58, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. S. Hreggvidsdottir, T. Östberg, H. Wähämaa et al., “The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation,” Journal of Leukocyte Biology, vol. 86, no. 3, pp. 655–662, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. E. Bianchi, “HMGB1 loves company,” Journal of Leukocyte Biology, vol. 86, no. 3, pp. 573–576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Ivanov, A. M. Dragoi, X. Wang et al., “A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA,” Blood, vol. 110, no. 6, pp. 1970–1981, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Barqasho, P. Nowak, S. Abdurahman, L. Walther-Jallow, and A. Sönnerborg, “Implications of the release of high-mobility group box 1 protein from dying cells during human immunodeficiency virus type 1 infection in vitro,” Journal of General Virology, vol. 91, no. 7, pp. 1800–1809, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. V. Sitaraman, J. M. Klapproth, D. A. Moore et al., “Elevated flagellin-specific immunoglobulins in Crohn's disease,” American Journal of Physiology, vol. 288, no. 2, pp. G403–G406, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T. R. Ziegler, M. Luo, C. F. Estívariz et al., “Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome,” American Journal of Physiology, vol. 294, no. 2, pp. R402–R410, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Jiang, M. M. Lederman, P. Hunt et al., “Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection,” Journal of Infectious Diseases, vol. 199, no. 8, pp. 1177–1185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. N. G. Sandler, H. Wand, A. Roque et al., “Plasma levels of soluble CD14 independently predict mortality in HIV infection,” Journal of Infectious Diseases, vol. 203, no. 6, pp. 780–790, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Troseid, A. Sönnerborg, and P. Nowak, “High mobility group box protein-1 in HIV-1 infection: connecting microbial translocation, cell death and immune activation,” Current HIV Research, vol. 9, no. 1, pp. 6–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Tian, A. M. Avalos, S. Y. Mao et al., “Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE,” Nature Immunology, vol. 8, no. 5, pp. 487–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Vijay-Kumar and A. T. Gewirtz, “Flagellin: key target of mucosal innate immunity,” Mucosal Immunology, vol. 2, no. 3, pp. 197–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Hayashi, K. D. Smith, A. Ozinsky et al., “The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5,” Nature, vol. 410, no. 6832, pp. 1099–1103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Vijay-Kumar, J. D. Aitken, and A. T. Gewirtz, “Toll like receptor-5: protecting the gut from enteric microbes,” Seminars in Immunopathology, vol. 30, no. 1, pp. 11–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. J. Lodes, Y. Cong, C. O. Elson et al., “Bacterial flagellin is a dominant antigen in Crohn disease,” Journal of Clinical Investigation, vol. 113, no. 9, pp. 1296–1306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Vijay-Kumar and A. T. Gewirtz, “Role of flagellin in Crohn's disease: emblematic of the progress and enigmas in understanding inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 15, no. 5, pp. 789–795, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. T. Gewirtz, T. A. Navas, S. Lyons, P. J. Godowski, and J. L. Madara, “Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression,” Journal of Immunology, vol. 167, no. 4, pp. 1882–1885, 2001. View at Google Scholar · View at Scopus
  35. N. Funderburg, A. A. Luciano, W. Jiang, B. Rodriguez, S. F. Sieg, and M. M. Lederman, “Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis,” PLoS ONE, vol. 3, no. 4, Article ID e1915, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Thibault, M. Imbeault, M. R. Tardif, and M. J. Tremblay, “TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells,” Virology, vol. 389, no. 1-2, pp. 20–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. H. J. Epple, T. Schneider, H. Troeger et al., “Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients,” Gut, vol. 58, no. 2, pp. 220–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. S. R. Targan, C. J. Landers, H. Yang et al., “Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease,” Gastroenterology, vol. 128, no. 7, pp. 2020–2028, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Kamat, P. Ancuta, R. S. Blumberg, and D. Gabuzda, “Serological markers for inflammatory bowel disease in aids patients with evidence of microbial translocation,” PLoS ONE, vol. 5, no. 11, Article ID e15533, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Collin, C.-S. Li, Z.-M. Ma, H. Overman, and T. Knight, “Shifts in proportions of higher-taxa bacterial orders measured by 16S rDNA PCR in the stools of HIV patients following ART and correlations with HIV immunopathogenesis,” in Proceedings of the 18th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, USA, 2011.
  41. R. M. Macnab, “How bacteria assemble flagella,” Annual Review of Microbiology, vol. 57, pp. 77–100, 2003. View at Publisher · View at Google Scholar · View at Scopus